Faeezah Patel

ORCID: 0000-0003-1503-2016

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant”.

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

New England Journal of Medicine(2021)10.1056/nejmoa2102214

N/A

13.3DataRank · unranked

1321 citations

Vicky L. Baillie, Clare Cutland, Merryn Voysey, Anthonet Koen, Lee Fairlie +46 more

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

The Lancet(2022)10.1016/s0140-6736(22)00007-1

N/A

4.4DataRank · unranked

85 citations

Nigel Garrett, Ameena Goga, Lara Fairall, Tarylee Reddy, Nonhlanhla Yende-Zuma +76 more

Early antiretroviral treatment of infants to attain HIV remission

EClinicalMedicine(2020)10.1016/j.eclinm.2019.100241

N/A

1.9DataRank · unranked

57 citations

Renate Strehlau, Stephanie Shiau, Faeezah Patel, Yanhan Shen, Karl‐Günter Technau +9 more

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00061-9

N/A

1.1DataRank · unranked

30 citations

Lauren Ziemba, Sean S. Brummel, Katie McCarthy, Anne Coletti, Chelsea Krotje +95 more

Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

The Lancet HIV(2024)10.1016/s2352-3018(23)00300-4

N/A

1.1DataRank · unranked

29 citations

Edmund V. Capparelli, Katherine Calabrese, Kristin Baltrusaitis, Mark A. Marzinke, Cynthia McCoig +36 more

Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study

The Lancet HIV(2024)10.1016/s2352-3018(23)00301-6

N/A

0.959DataRank · unranked

26 citations

Jennifer Chapman, Rachel Ohrenschall, Katherine Calabrese, Kristin Baltrusaitis, Barbara Heckman +32 more

Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1–2 dose-confirmation study

The Lancet HIV(2023)10.1016/s2352-3018(23)00107-8

N/A

0.675DataRank · unranked

13 citations

Jennifer J. Kiser, Lauren Ziemba, S. M. Ward, Yasha Rani, Tim R. Cressey +24 more

Predictors of Cell-Associated Human Immunodeficiency Virus (HIV)-1 DNA Over 1 Year in Very Early Treated Infants

Clinical Infectious Diseases(2021)10.1093/cid/ciab586

N/A

0.608DataRank · unranked

14 citations

Maria Paximadis, Bianca Da Costa Dias, Yanhan Shen, Sizanani Mncube, Renate Strehlau +9 more

Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

The Lancet HIV(2025)10.1016/s2352-3018(24)00344-8

N/A

0.535DataRank · unranked

12 citations

Kristin Baltrusaitis, Brookie M. Best, Jack Moye, Ellen Townley, Avy Violari +36 more

Growth Trajectories Over the First Year of Life Among Early-Treated Infants with Human Immunodeficiency Virus and Infants Who are Human Immunodeficiency Virus-Exposed Uninfected

The Journal of Pediatrics(2024)10.1016/j.jpeds.2024.114018

N/A

0.104DataRank · unranked

1 citations

Renate Strehlau, Faeezah Patel, Megan Burke, Stephanie Shiau, Yanhan Shen +5 more

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants

medRxiv(2023)10.1101/2023.11.20.23298785

N/A

0DataRank · unranked

5 citations

Jinal N. Bhiman, Yashica Ganga, Shobna Sawry, Frances Ayres, Richard Baguma +51 more

Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa

medRxiv(2021)10.1101/2021.02.10.21251247

N/A

0DataRank · unranked

122 citations

Vicky L. Baillie, Clare Cutland, Merryn Voysey, Anthonet Koen, Lee Fairlie +48 more

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants

PLOS Global Public Health(2024)10.1371/journal.pgph.0002703

N/A

0DataRank · unranked

12 citations

Jinal N. Bhiman, Yashica Ganga, Shobna Sawry, Frances Ayres, Richard Baguma +51 more